Abstract: Embodiments of the disclosure disclose a store system, and a method and an apparatus for processing information of clothing items for try-on. The store system comprises: a first device, deployed in a back warehouse area of a store and configured to obtain corresponding relationship between a user and information of one or more clothing items for try-on; and provide preparation prompt information based on the corresponding relationship to prepare the one or more clothing items for the user; and a fitting room, the fitting room comprising a first door and a second door, the first door configured for the user to enter and exit the fitting room, and the second door configured for delivering the one or more clothing items for try-on corresponding to the user from the back warehouse area to the fitting room.

Abstract: Fried confectionery food products such as doughnuts and mini doughnuts, compositions, and methods for making wherein the confectionery food products have an extended shelf-life of from more than three (3) months up to nine (9) months where water activity, moisture loss and undesirable flavor and texture changes are controlled.

Abstract: A network management system (NMS) is described that provides a granular troubleshooting workflow at an application session level using an application session-specific topology from a client device to a cloud-based application server. During an application session of a cloud-based application, a client device running the application exchanges data through one or more access point (AP) devices, one or more switches at a wired network edge, and one or more network nodes, e.g., switches, routers, and/or gateway devices, to reach a cloud-based application server. For a particular application session, the NMS generates a topology based on network data received from a subset of network devices, e.g., client devices, AP devices, switches, routers, and/or gateways, that were involved in the particular application session over a duration of the particular application session. In this way, the NMS enables backward-looking troubleshooting of the particular application session.

Abstract: A network management system (NMS) is described that provides a granular troubleshooting workflow at an application session level using an application session-specific topology from a client device to a cloud-based application server. During an application session of a cloud-based application, a client device running the application exchanges data through one or more access point (AP) devices, one or more switches at a wired network edge, and one or more network nodes, e.g., switches, routers, and/or gateway devices, to reach a cloud-based application server. For a particular application session, the NMS generates a topology based on network data received from a subset of network devices, e.g., client devices, AP devices, switches, routers, and/or gateways, that were involved in the particular application session over a duration of the particular application session. In this way, the NMS enables backward-looking troubleshooting of the particular application session.

Abstract: The present disclosure relates to reduced sugar content milk chocolate confection and confectionery products comprising at least one rare sugar, such as allulose, methods of making the same wherein the confections and confectionery products have desirable rheological properties and organoleptic properties and stable viscosity over time. The present disclosure also relates to preventing thickening of reduced sugar content milk chocolate confections comprising at least one rare sugar, such as allulose, during manufacturing, and maintaining stable viscosity over time.

Abstract: The disclosure discloses a fatty acid synthase inhibitor and application thereof and belongs to the technical field of medical biology. The fatty acid synthase inhibitor of the disclosure can significantly inhibit the activity of fatty acid synthase without affecting normal expression, and adjust the ratio of fatty acids in cells. The fatty acid synthase inhibitor of the disclosure has a good tumor proliferation inhibitory effect, can arrest the growth cycle of tumor cells in the interphase, prevent tumor cell division, inhibit tumor cell proliferation, promote tumor cell apoptosis and exert a tumor treatment effect, can be used to treat tumors and metabolism related diseases, and has an important clinical application prospect.

Abstract: A dairy-free, gluten free and vegan chocolate confection and method of making the same are disclosed. In the chocolate confection of the invention, the milk solids present in traditional milk chocolate are replaced by heat-treated legume flour. The heat-treated legume flour imparts desirable flavor and texture characteristics to the chocolate confection. The legume flours have relatively low levels of sugar and high levels of protein and fiber. They are also suitable for reduced-sugar chocolate formulations.

Abstract: An interventional operation isolation transfer cabin includes a cabin body, and a lead wire access device and a wire in/out device which two are mounted on the cabin body, the cabin body is provided with a negative pressure generating device at one end and an air inlet at the other end, the negative pressure generating device is provided with an exhaust filter device at its air outlet, and an intake filter device is provided at the air inlet. Several operating openings are provided on side walls of the cabin body, each of the operating openings is in seal connection with an operating glove, and a glove opening of at least one operating glove faces an interior of the cabin body. Equipment wires required by an interventional operation are preset through the lead wire access device, and wires added midway under a sealing condition is guaranteed through the wire in/out device.

Abstract: The present disclosure relates to reduced sugar content milk chocolate confection and confectionery products comprising at least one rare sugar, such as allulose, methods of making the same wherein the confections and confectionery products have desirable rheological properties and organoleptic properties and stable viscosity over time. The present disclosure also relates to preventing thickening of reduced sugar content milk chocolate confections comprising at least one rare sugar, such as allulose, during manufacturing, and maintaining stable viscosity over time.

Abstract: A process of preparing a marshmallow piece includes preparing a pre-cook syrup batch of a mixture including a low viscosity saccharidic composition, humectant, and water as a pre-cook syrup batch. The low viscosity saccharidic composition includes at least two low viscosity saccharidic components and at least one polysaccharide. The process also includes cooking the pre-cook syrup batch to form a cooked syrup composition having a predetermined moisture content, combining the cooked syrup composition with a gelatin solution and optionally at least one flavoring to form a pre-whip marshmallow composition, whipping the pre-whip marshmallow composition to form a whipped marshmallow composition having a predetermined density, and forming and setting up a formed marshmallow composition to form the marshmallow piece. The marshmallow has a water activity in the range of between 0.40 and 0.45. A comestible includes the marshmallow and at least one dry portion having a crunchy texture.

Abstract: Disclosed is an application of Stachyose in preparation of a drug for treating castration-resistant prostate cancer, belonging to the technical field of biological medicine. The disclosure proposes a new strategy of using Stachyose in combination with an androgen receptor antagonist to prepare a drug for treating CRPC for the first time, and conducts multi-angle and multi-level verification research. The drug composition of the Stachyose in combination with the androgen receptor in the disclosure can be used for treating castration-resistant prostate cancer, and significantly improves the effect of Enzalutamide on inhibiting castration-resistant prostate cancer. The natural compound is applied to the advanced stage of cancer, and has important clinical therapeutic significance.

Abstract: The present disclosure discloses use of polaprezinc (Pola) in preparing a drug for treating castration-resistant prostate cancer (CRPC) and belongs to the technical field of biological medicine. The present disclosure provides a new strategy for preparing the drug for treating the CRPC by combining the Pola with an androgen receptor antagonist for the first time and conducts a multi-angle and multi-level verification research. A drug composition combining the polaprezinc and the androgen receptor antagonist can be used for treating castration-resistant prostate cancer, remarkably improves an effect of enzalutamide in inhibiting the castration-resistant prostate cancer, realizes new use of the old drug, can greatly shorten time from drug discovery to clinical transformation, and has important clinical treatment significance.

Abstract: A modified cake formula and baking process to have a shelf-stable food product, especially micro-safe cake with water activity (Aw) less than about 0.71, less than about 0.7 or ideally less than about 0.65. The process involves grinding the baked cake fine crumbs, and blending the resulting crumbs with a binding agent to make a cake truffle, wherein the cake truffle has a water into activity less than around 0.7, and optionally covering the cake truffle with a confectionary coating, or with milk chocolate.

Abstract: A dairy-free and vegan chocolate confection and method of making the same are disclosed. In the confection of the invention, the milk solids present in traditional milk chocolate are replaced by grain flour.

Abstract: A reduced calorie filling composition may include a chocolate component and an aqueous component. The chocolate component may be present in an amount from about 30% to about 70% by weight of the reduced calorie filling composition. The aqueous component may include water in an amount from about 9% to about 20% by weight of the reduced calorie filling composition. In addition, the aqueous component may include a sweetener component in an amount from about 5% to about 30% by weight of the reduced calorie filling composition. The aqueous component may also includes a humectant in an amount from about 2% to about 10% by weight of the reduced calorie filling composition. A confectionery product may be a finished reduced calorie confectionery product having a reduced calorie coating composition on the reduced calorie filling composition. The finished reduced calorie confectionery product may be a reduced calorie truffle.

Abstract: Disclosed are a chitin/graphene composite sponge and a preparation method and a use thereof. The method comprises mixing and ball-milling a certain amount of flake graphite and chitin, dissolving a mixture of the flake graphite and the chitin in a NaOH/urea solvent, performing centrifugal separation, dispersing evenly, cross-linking with an epichlorohydrin cross-linking agent, standing, dialyzing, and freeze-drying, thus obtaining the chitin/graphene composite sponge.

Abstract: The present disclosure provides an electrochemical energy storage device including a housing. The housing includes a first side wall and a second side wall opposite to the first side wall, and defines a chamber configured for receiving a battery cell. The chamber is between the first side wall and the second side wall. At least one of the first side wall and the second side wall carries a reinforcing layer. The reinforcing layer improves the structural strength of the housing. When the electrochemical energy storage device is dropped or impacted, the reinforcing layer protects the housing, thereby avoiding a short circuit of the electrochemical energy storage device or leakage of the electrolyte, thereby improving the safety and reliability of the electrochemical energy storage device.

Abstract: A coated particle may include a food particle coated by a carbohydrate. The coated particle may have an average particle size from about 10 ?m to about 250 ?m. The food particle may include a relatively bitter component (e.g., cocoa) and a protein component (e.g., whey protein, soy protein, rice protein, fava bean protein, and/or milk protein). A weight ratio of bitter component to protein component may be about 3 or greater. The food particle may also include a starch, such as rice starch. Additionally, the coated particle may have a surface area fraction of the carbohydrate that is greater than an average weight fraction of the carbohydrate. For example, the surface area fraction of the carbohydrate may be from about 30% to about 80%. In addition, the coated particle may have a substantially non-spherical and irregular shape. The coated particle may be prepared via a spray drying process.

Abstract: The disclosure discloses a fatty acid synthase inhibitor and application thereof and belongs to the technical field of medical biology. The fatty acid synthase inhibitor of the disclosure can significantly inhibit the activity of fatty acid synthase without affecting normal expression, and adjust the ratio of fatty acids in cells. The fatty acid synthase inhibitor of the disclosure has a good tumor proliferation inhibitory effect, can arrest the growth cycle of tumor cells in the interphase, prevent tumor cell division, inhibit tumor cell proliferation, promote tumor cell apoptosis and exert a tumor treatment effect, can be used to treat tumors and metabolism related diseases, and has an important clinical application prospect.